Jennifer Schumi

1.2k total citations
16 papers, 663 citations indexed

About

Jennifer Schumi is a scholar working on Physiology, Pharmacology and Artificial Intelligence. According to data from OpenAlex, Jennifer Schumi has authored 16 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Pharmacology and 3 papers in Artificial Intelligence. Recurrent topics in Jennifer Schumi's work include Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Jennifer Schumi is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Jennifer Schumi collaborates with scholars based in United States, Sweden and United Kingdom. Jennifer Schumi's co-authors include Janet Wittes, Lyle Ungar, Jason Schweinsberg, Richard D. De Veaux, Philippe L. L’Allier, Robert J. Small, Eric Klug, Marc A. Pfeffer, John J.V. McMurray and Robert C. Scott and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Jennifer Schumi

15 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Schumi United States 9 132 89 88 84 73 16 663
Mohammad Ehsanul Karim Canada 17 58 0.4× 128 1.4× 212 2.4× 198 2.4× 62 0.8× 122 1.3k
Kang Zou China 17 133 1.0× 63 0.7× 128 1.5× 45 0.5× 25 0.3× 130 1.1k
Bruno Scherrer France 17 122 0.9× 70 0.8× 40 0.5× 118 1.4× 44 0.6× 53 1.5k
Mauro Gasparini Italy 18 114 0.9× 91 1.0× 51 0.6× 279 3.3× 29 0.4× 61 1.1k
Sofía S. Villar United Kingdom 15 73 0.6× 168 1.9× 72 0.8× 367 4.4× 40 0.5× 57 1.0k
Lu Lin China 13 119 0.9× 80 0.9× 66 0.8× 243 2.9× 11 0.2× 51 979
Zhengqing Li China 16 88 0.7× 54 0.6× 29 0.3× 92 1.1× 34 0.5× 64 748
Marlos A. G. Viana United States 26 141 1.1× 31 0.3× 93 1.1× 84 1.0× 29 0.4× 73 2.1k
Dukyong Yoon South Korea 22 216 1.6× 42 0.5× 116 1.3× 25 0.3× 49 0.7× 99 1.4k
Artur Akbarov United Kingdom 13 40 0.3× 35 0.4× 50 0.6× 40 0.5× 27 0.4× 19 611

Countries citing papers authored by Jennifer Schumi

Since Specialization
Citations

This map shows the geographic impact of Jennifer Schumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Schumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Schumi more than expected).

Fields of papers citing papers by Jennifer Schumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Schumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Schumi. The network helps show where Jennifer Schumi may publish in the future.

Co-authorship network of co-authors of Jennifer Schumi

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Schumi. A scholar is included among the top collaborators of Jennifer Schumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Schumi. Jennifer Schumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ericson, Elke, Anne‐Christine Andréasson, Carly I. Dix, et al.. (2022). Hepatic patatin‐like phospholipase domain‐containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans. Hepatology Communications. 6(10). 2689–2701. 14 indexed citations
2.
Koren, Michael J., Alexis Hofherr, Jennifer Schumi, et al.. (2022). ETESIAN: A PHASE 2B STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF AZD8233, A PCSK9-TARGETED ANTISENSE OLIGONUCLEOTIDE, IN PATIENTS WITH DYSLIPIDEMIA. Journal of the American College of Cardiology. 79(9). 1475–1475. 14 indexed citations
3.
4.
Hofherr, Alexis, Jennifer Schumi, Dinko Rekić, et al.. (2022). ETESIAN: A phase 2B study of the efficacy, safety and tolerability of AZD8233, a PCSK9-targeted antisense oligonucleotide, in patients with dyslipidemia. Atherosclerosis. 355. 28–28. 6 indexed citations
5.
Liu‐Seifert, Hong, Jennifer Schumi, Xiaopeng Miao, et al.. (2020). Disease Modification in Alzheimer’s Disease: Current Thinking. Therapeutic Innovation & Regulatory Science. 54(2). 396–403. 16 indexed citations
6.
Liu‐Seifert, Hong, Jennifer Schumi, Xiaopeng Miao, et al.. (2019). Disease Modification in Alzheimer’s Disease: Current Thinking. Therapeutic Innovation & Regulatory Science. 3593143741–3593143741. 1 indexed citations
7.
Sims, John R., AnnCatherine M. Downing, Scott W. Andersen, et al.. (2018). DT‐01‐04: LANABECESTAT: BASELINE CHARACTERISTICS OF PARTICIPANTS RANDOMIZED IN THE PHASE 2/3 AMARANTH STUDY. Alzheimer s & Dementia. 14(7S_Part_31).
8.
Sims, John R., Katherine J. Selzler, AnnCatherine M. Downing, et al.. (2017). Development Review of the BACE1 Inhibitor Lanabecestat (AZD3293/LY3314814).. PubMed. 4(4). 247–254. 18 indexed citations
9.
Schumi, Jennifer, et al.. (2016). Assessment of the Cardiovascular Risk of Olmesartan Medoxomil-Based Treatment: Meta-Analysis of Individual Patient Data. American Journal of Cardiovascular Drugs. 16(6). 427–437. 1 indexed citations
10.
Schumi, Jennifer & Janet Wittes. (2011). Through the looking glass: understanding non-inferiority. Trials. 12(1). 106–106. 283 indexed citations
11.
Schumi, Jennifer, A. Gregory DiRienzo, & Victor DeGruttola. (2008). Testing for Associations with Missing High-Dimensional Categorical Covariates. The International Journal of Biostatistics. 4(1). Article 18–Article 18. 1 indexed citations
12.
Tardif, Jean‐Claude, John J.V. McMurray, Eric Klug, et al.. (2008). Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. The Lancet. 371(9626). 1761–1768. 147 indexed citations
13.
Schumi, Jennifer & Victor DeGruttola. (2008). Resampling‐based analyses of the effects of combinations of HIV genetic mutations on drug susceptibility. Statistics in Medicine. 27(23). 4740–4757. 4 indexed citations
14.
Mello, Michelle M., David M. Studdert, Jennifer Schumi, Troyen A. Brennan, & William M. Sage. (2007). Changes In Physician Supply And Scope Of Practice During A Malpractice Crisis: Evidence From Pennsylvania. Health Affairs. 26(Suppl2). w425–w435. 20 indexed citations
15.
Veaux, Richard D. De, Jennifer Schumi, Jason Schweinsberg, & Lyle Ungar. (1998). Prediction Intervals for Neural Networks via Nonlinear Regression. Technometrics. 40(4). 273–273. 116 indexed citations
16.
Schumi, Jennifer, et al.. (1998). Prediction Intervals for Neural Networks via Nonlinear Regression. Technometrics. 40(4). 273–282. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Ehsanul Karim Breakdown of academic impact, for papers by Kang Zou Breakdown of academic impact, for papers by Bruno Scherrer Breakdown of academic impact, for papers by Mauro Gasparini Breakdown of academic impact, for papers by Sofía S. Villar Breakdown of academic impact, for papers by Lu Lin Breakdown of academic impact, for papers by Zhengqing Li Breakdown of academic impact, for papers by Marlos A. G. Viana Breakdown of academic impact, for papers by Dukyong Yoon Breakdown of academic impact, for papers by Artur Akbarov
Rankless by CCL
2026